| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 05/14/2009 | US20090124610 Pharmaceutical compounds |
| 05/13/2009 | EP2057116A1 New phenylsulfamoyl benzamide derivatives as bradykinin antagonists |
| 05/13/2009 | EP2057109A2 Addition reactions using transition metal catalysts in halogenated solvents |
| 05/13/2009 | CN101429194A Process for the preparation of tryptase inhibitors |
| 05/13/2009 | CN101429155A Azacyclo-amino substituted tetracycline derivant |
| 05/13/2009 | CN101429154A Anhydrous alvimopan and medicament composition thereof |
| 05/13/2009 | CN100486573C Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and use |
| 05/12/2009 | US7531668 2-arylcarboxamide-nitrogenous heterocycle compound |
| 05/12/2009 | US7531664 Having at least one sterically hindered nitroxyl, hydroxylamine or hydrocarbyloxyamine moiety and at least one conventional organohalogen or organophosphorus flame retardant moiety: 1-cyclohexyloxy-2,2,6,6-tetramethyl-4-piperidinyl diphenyl phosphate; fireproofing organic polymer substrates |
| 05/12/2009 | US7531661 Such as N-methyl(1-{2-[(1R,5S)-3-(2-methyl-1H-benzimidazol-1-yl)-8-azabicyclo[3.2.1]oct-8-yl]ethyl}-2,3-dihydro-1H-inden-1-yl)methanamine; chemokine receptor antagonists; prevention or treatment of a human T-cell leukemia/lymphoma virus infection |
| 05/12/2009 | US7531656 Synthesis of gatifloxacin |
| 05/12/2009 | US7531555 Central nervous system disorders; schizophrenia; anxiolytic agents; Alzheimer's disease; Huntington's disease |
| 05/12/2009 | US7531549 2-[(2-Isopropylsulfanyl-3-oxo-spiro[3.5]non-1-en-1-yl)amino]-3-[4-([2,7]naphthyridin-1-ylamino)phenyl]propanoic acid; compounds can inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders |
| 05/12/2009 | US7531535 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors |
| 05/12/2009 | CA2389156C Benzamidine derivatives |
| 05/12/2009 | CA2341891C The use of r(+)-.alpha.-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol for the treatment of sleep disorders |
| 05/07/2009 | WO2009058924A1 Ccr5 antagonists as therapeutic agents |
| 05/07/2009 | WO2009058923A1 Ccr5 antagonists as therapeutic agents |
| 05/07/2009 | WO2009058921A1 Ccr5 antagonists as therapeutic agents |
| 05/07/2009 | WO2009058919A1 Ccr5 antagonists as therapeutic agents |
| 05/07/2009 | WO2009058314A1 Enantioselective process for preparing a substituted alkanoic acid |
| 05/07/2009 | WO2009056707A2 Indol-2-one derivatives disubstituted in the 3-position, preparation thereof and therapeutic use thereof |
| 05/07/2009 | WO2008156828A3 Renin inhibitors |
| 05/07/2009 | WO2006058182A3 Lighting elements, devices and methods |
| 05/07/2009 | US20090118513 Chemical Compounds |
| 05/07/2009 | US20090118512 Process for Preparing 6,7-Dihydro-5H-Imidazo[1,5-A]Pyridin-8-One |
| 05/07/2009 | US20090118339 Lysine related derivatives as hiv aspartyl protease inhibitors |
| 05/07/2009 | US20090118338 Aryl amides useful as inhibitors of voltage-gated sodium channels |
| 05/07/2009 | US20090118332 Therapeutic Agents - 551 |
| 05/07/2009 | US20090118330 Diurea derivatives |
| 05/07/2009 | US20090118305 Pyridine and pyrazine derivatives - 083 |
| 05/07/2009 | US20090118283 Amide Derivatives as Kinase Inhibitors |
| 05/07/2009 | US20090118267 Indanes |
| 05/07/2009 | US20090118257 4-(p-QUINONYL)-2-HYDROXYBUTANAMIDE DERIVATIVES FOR TREATMENT OF MITOCHONDRIAL DISEASES |
| 05/07/2009 | CA2696237A1 Indol-2-one derivatives disubstituted in the 3-position, preparation thereof and therapeutic use thereof |
| 05/06/2009 | EP2054385A2 Phenyl, pyridine and quinoline derivatives |
| 05/06/2009 | EP1465861B1 Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors |
| 05/06/2009 | EP1385506B1 Acylated piperidine derivates as melanocortin-4 receptor agonists |
| 05/06/2009 | EP1308440B1 Piperidine derivatives and drugs containing these derivatives as the active ingredient |
| 05/06/2009 | CN101426787A Processes for the synthesis of 3-isobutylglutaric acid |
| 05/06/2009 | CN101426765A Crystalline forms of a dimethylphenyl compound |
| 05/06/2009 | CN101426764A Dialkylphenyl compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 05/06/2009 | CN101426486A Compounds for the treatment of inflammatory disorders and microbial diseases |
| 05/06/2009 | CN101423481A Diketohydrazine derivative compound and medicine containing the compound as active ingredient |
| 05/06/2009 | CN100486030C Electrolytic solution and battery |
| 05/06/2009 | CN100484923C Process of synthesizing fexofenadine intermediate |
| 05/05/2009 | US7528255 Hydroxy, ω-carboxyaryl substituted diphenyl ureas and dirivatives thereof as raf kinase inhibitors |
| 05/05/2009 | US7528173 Plasma carboxypeptidase B inhibitors |
| 05/05/2009 | US7528156 Such as N-[2-(3-{[1-(3,4-dichlorobenzylpiperidinyl]aminohydroxypropoxy)phenyl]acetamide; antiinflammatory agents, antiarthritic agents; chronic obstructive pulmonary disease, asthma, multiple sclerosis |
| 05/05/2009 | US7528154 Polyarylcarboxamides useful as lipid lowering agents |
| 05/05/2009 | US7528153 Deoxynojirimycin analogues and their uses as glucosylceramidase inhibitors |
| 05/05/2009 | US7528152 synthetic analog of Hemiasterlin; anticarcinogenic agent; restenosis of blood vessels subject to traumas such as angioplasty and stenting; safe and effective, while retaining stability in biological media; exhibit low cytotoxicity to non-dividing normal cells |
| 05/05/2009 | US7528134 Acetamides and benzamides that are useful in treating sexual dysfunction |
| 05/05/2009 | CA2513549C Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
| 05/05/2009 | CA2448281C Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine and the use thereof for the preparation of pyrrolo 2,3-pyrimidine derivatives as protein kinases inhibitors |
| 05/05/2009 | CA2347863C Treatment of disorders of the outer retina |
| 04/30/2009 | WO2009054434A1 Amine derivative having npy y5 receptor antagonist activity and use thereof |
| 04/30/2009 | WO2009054202A1 Process for producing organic compound and organic compound obtained by the same |
| 04/30/2009 | WO2009053763A1 New non-peptide derivatives as bradykinin b1 antagonists |
| 04/30/2009 | WO2009052708A1 1-(3-amino-propyl)-piperidin-4-yl-amides, pharmaceutical compositions, processes for their preparation and uses |
| 04/30/2009 | WO2009021943A3 Novel preparation process |
| 04/30/2009 | WO2007056016A3 Bisamide cytokine inhibitors |
| 04/30/2009 | US20090111993 Process for Preparing Beta-(Fluorophenyl)-Propanoate Ester Derivatives |
| 04/30/2009 | US20090111854 1,2,4-triazole aryl n-oxides derivatives as modulators of mglur5 |
| 04/30/2009 | US20090111853 Fexofenadine polymorphs and process for the preparation thereof |
| 04/30/2009 | US20090111808 Novel histamine h3-receptor ligands and their therapeutic applications |
| 04/30/2009 | US20090111791 Soluble Epoxide Hydrolase Inhibitors and Methods of Using Same |
| 04/30/2009 | US20090111699 Weakly Basic Hindered Amines Having Carbonate Skeletons, Synthetic Resin Compositions, And Coating Compositions |
| 04/30/2009 | US20090111183 Ketone Ligands for Modulating the Expression of Exogenous Genes Via An Ecdysone Receptor Complex |
| 04/30/2009 | CA2703797A1 Amine derivative having npy y5 receptor antagonist activity and use thereof |
| 04/30/2009 | CA2703290A1 New non-peptide derivatives as bradykinin b1 antagonists |
| 04/30/2009 | CA2699933A1 Fungicidal mixtures |
| 04/29/2009 | EP2053048A1 Chemical in situ sulphonating process |
| 04/29/2009 | EP2051963A1 Process for resolving chiral piperidine alcohol and process for synthesis of pyrazolo [1,5-a]pyrimidine derivatives using same |
| 04/29/2009 | EP1771421B1 N-hydroxyamide derivatives and use thereof |
| 04/29/2009 | EP1511472B1 Compounds useful in the treatment of anthrax and inhibiting lethal factor |
| 04/29/2009 | EP1438288B1 Substituted thioacetamides |
| 04/29/2009 | CN101421258A Sulfonyl-substituted bicyclic compounds as modulators of ppar |
| 04/29/2009 | CN101421257A Agents that disrupt cellular replication and their use in inhibiting pathological conditions |
| 04/29/2009 | CN101421234A Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptor |
| 04/29/2009 | CN101417964A Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 04/29/2009 | CN100482800C Steroselective preparation of cyclic L-amino acids |
| 04/29/2009 | CN100482646C Derivative of n-[phenyl(piperidin-2-yl)methyl]benzamide, the preparation method thereof and application of same in therapeutics |
| 04/29/2009 | CN100482229C Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists |
| 04/28/2009 | USRE40703 N-(2-aminophenyl)-4-(N-benzoylaminomethyl)benzamide hydrochloride; differentiation-inducing activity, for malignant tumors, autoimmune diseases, dermatologic diseases and parasitism, hematologic malignancy, a solid carcinoma |
| 04/28/2009 | US7524968 2-pyridinylcycloalkylbenzamide derivatives and their use as fungicides |
| 04/28/2009 | US7524965 Dialkylphenyl compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 04/28/2009 | US7524964 Tetrahydrothiopyrano pyrazole cannabinoid modulators |
| 04/28/2009 | US7524963 Antiinflammatory agents; rheumatic diseases |
| 04/28/2009 | US7524962 Biphenyl compounds useful as muscarinic receptor antagonists |
| 04/28/2009 | US7524959 Biphenyl-2-ylcarbamic acid 1-[2-(2-chloro-4-{[(R)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethylamino]methyl}-5-methoxyphenyl-carbamoyl)ethyl]piperidin-4-yl ester; beta 2 adrenergic receptor agonist and muscarinic receptor antagonist; bronchodilator agent; pulmonary disorders, asthma |
| 04/28/2009 | US7524873 Substituted N-phenylmethyl ethanamines; N-((6-(methyloxy)-4'-(trifluoromethyl)-1,1'-biphenyl-3-yl)methyl)-1-(1-naphthalenyl)ethanamine; parathyroid hormone inhibitors; antisecretory agents; osteoporosis |
| 04/28/2009 | US7524864 Methods of treating sleep disorders |
| 04/28/2009 | US7524863 Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors |
| 04/28/2009 | US7524846 heterocylcyclic amines used for treating or preventing conditions ameliorated by monoamine reuptake such as vasomotor symptoms, sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders |
| 04/28/2009 | CA2507465C Phenyl substituted piperidine compounds for use as ppar activators |
| 04/28/2009 | CA2380074C Novel amide derivatives |
| 04/23/2009 | WO2009052341A1 Gsm intermediates |
| 04/23/2009 | WO2009052126A1 PIPERIDINYL AND PIPERAZINYL MODULATORS OF γ-SECRETASE |
| 04/23/2009 | WO2009051244A1 Heterocyclic compound |